TLSA Stock Price
Tiziana Life Sciences Ltd
TLSA stock price is $1.13 (+2.73% on the day), giving Tiziana Life Sciences Ltd a market cap of $143.80M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
TLSA Stock Overview
- Price
- $1.13
- Previous close
- $1.10
- Open
- $1.11
- Market cap
- $143.80M
- P/E ratio
- -7.8
- 52-week range
- $0.76 - $2.33
- 1-year price target
- $8.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 37
About Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), an orally bioavailable small molecule broad spectrum inhibitor of various cyclin-dependent kinases and Src family; and TZLS-501, a fully human mAb targeting the IL-6 receptor for the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TLSA | $1.13 | +2.7% | 448.03K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tiziana Life Sciences Ltd Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW